The National Institutes of Health (NIH) is supporting administrative supplement applications for funding from eligible investigators at National Institute of Allergy and Infectious Diseases (NIAID) Regional Biocontainment Laboratories (RBL) focused on efforts to prevent, prepare for, and respond to infectious disease outbreaks.
Active G20 Grants awarded under RFA-AI-21-022 Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories may request for Biosafety Level 3 (BSL-3) renovations and facilities upgrades or purchase of equipment for BSL-3.
RBL-Affiliated Research Projects: Applicants with active NIAID or NIH research grants that require a BSL-3 Biocontainment Facility and whose research projects are affiliated with one of the RBL sites for purposes of performance, whether the investigator is based at the RBL or another institution.
Example topics of interest include:
- Research projects requiring use of the RBL and related to the development and testing of new antiviral compounds or other therapeutics, new vaccines, and point of care diagnostics tests.
- Research projects requiring use of the RBL on other prophylactic methods to prevent infections.
- Training new researchers in BSL-3 practices.
The proposed supplemental activities must be allowed within the original scope of the parent award. Construction activities will not be supported.
Notice of Special Interest (NOSI): Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and other NIH Grantees Conducting Research at RBL-affiliated Sites. Notice Number: NOT-AI-22-049. First Available Due Date: May 31, 2022. Expiration Date: 1 June 2022.